Dentium CO., LTD (KRX:145720)

Market Cap	420.12B -31.1%
Revenue (ttm)	356.03B -13.9%
Net Income	42.11B -51.0%
EPS	4,882.41 -51.0%
Shares Out	7.81M
PE Ratio	11.02
Forward PE	7.92
Dividend	600.00 (1.17%)
Ex-Dividend Date	Mar 20, 2026

Volume	19,651
Average Volume	49,805
Open	53,200
Previous Close	53,800
Day's Range	51,500 - 53,200
52-Week Range	43,100 - 85,500
Beta	0.78
RSI	57.29
Earnings Date	May 15, 2026

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2024, Dentium CO., LTD's revenue was 407.81 billion, an increase of 3.72% compared to the previous year's 393.19 billion. Earnings were 72.71 billion, a decrease of -24.67%.